PCUT BioPartners is interested in drug programs that have solid rationale and appropriate evidence supporting clinical trial in life-threatening diseases.
We are actively pursuing three clinical candidates in the neurodegenerative disease space.
Our interests include therapeutics in several classes of diseases. One of our non-profit affiliates has compiled a list of over 40 medically promising products that have been directed at unmet medical needs and have stalled in development for non-health related reasons. As we review these, we will continue to engage other companies and disease-specific foundations to find undervalued drug programs.